Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Accendra HealthACH +12.52%55 3-Year Share Buyback Ratio is 0.00 as of Jun. 2026. GuruFocus rates ACH with a GF Score™ of 55/100 and a GF Value™ of $5.27 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 70 Medical Distribution companies, Accendra Health ranks worse than 1428570% on this metric.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Accendra Health's current 3-Year Share Buyback Ratio was 0.00%.
The historical rank and industry rank for Accendra Health's 3-Year Share Buyback Ratio or its related term are showing as below:
During the past 13 years, Accendra Health's highest 3-Year Share Buyback Ratio was 1.10%. The lowest was -12.20%. And the median was -1.30%.
ACH's 3-Year Share Buyback Ratio is not ranked *
in the Medical Distribution industry.
Industry Median: -0.5 * Ranked among companies with meaningful 3-Year Share Buyback Ratio only.
Accendra Health (NYSE:ACH) 3-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Accendra Health 3-Year Share Buyback Ratio Related Terms
ACH vs FOCL, YI, COSM: 3-Year Share Buyback Ratio Comparison
For the Medical Distribution subindustry, Accendra Health's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accendra Health 3-Year Share Buyback Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Accendra Health's 3-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Accendra Health's 3-Year Share Buyback Ratio falls into.
Accendra Health 3-Year Share Buyback Ratio Calculation
This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 3-Year Share Buyback Ratio of 0.00 mean?
Accendra Health (ACH) has a 3-Year Share Buyback Ratio of 0.00 as of Jun. 2026. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Accendra Health and its competitors. According to the industry distribution chart, Accendra Health ranks #999999 out of 70 companies in the Medical Distribution industry.
Is Accendra Health's 3-Year Share Buyback Ratio too high?
Accendra Health's current 3-Year Share Buyback Ratio is 0.00. Based on the distribution chart, Accendra Health ranks #999999 out of 70 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Accendra Health has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Accendra Health's 3-Year Share Buyback Ratio compare to FOCL and YI?
According to the Medical Distribution industry distribution chart, Accendra Health ranks #999999 out of 70 companies for 3-Year Share Buyback Ratio. This places Accendra Health in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Share Buyback Ratio for a Medical Distribution company?
A good 3-Year Share Buyback Ratio depends on the Medical Distribution industry context. However, 3-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Share Buyback Ratio mean?
A high 3-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Accendra Health and its competitors. Accendra Health's current 3-Year Share Buyback Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accendra Health stock overvalued right now?
Based on GuruFocus' analysis, Accendra Health (ACH) is currently considered Possible Value Trap. The stock's GF Value™ is $5.27, compared to a current price of $1.07 — trading 79.7% below its estimated fair value. The current 3-Year Share Buyback Ratio is 0.00. Accendra Health's overall GF Score™ is 55/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Share Buyback Ratio calculated?
3-Year Share Buyback Ratio is calculated from a company's financial statements. For Accendra Health (ACH), the current 3-Year Share Buyback Ratio is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Accendra Health (ACH) Overvalued in 2026?
Based on GuruFocus' analysis, Accendra Health stock appears to be undervalued.
The current stock price of $1.07 is trading 79.7% below its estimated GF Value™ of $5.27.
GuruFocus considers Accendra Health to be Possible Value Trap.
Key valuation signals for ACH:
3-Year Share Buyback Ratio: 0.00
GF Value™: $5.27 vs. price of $1.07 (79.7% below fair value)
No single metric tells the full story. See the ACH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
55GF Score
Get the complete analysis for ACH
3-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ACH has been successfully added to your 
